Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells

scientific article

Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12013-009-9058-3
P698PubMed publication ID19593673

P2093author name stringEkram M Saleh
Abdel Hady A Abdel Wahab
Mervat A Abdel Alim
Raafat A El-Awady
P2860cites workRequirement for p53 and p21 to sustain G2 arrest after DNA damageQ29547667
G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cellsQ34792908
Mammalian cell cycle checkpoints: signalling pathways and their organization in space and timeQ35848480
P433issue2
P921main subjectdoxorubicinQ18936
P304page(s)95-105
P577publication date2009-07-11
P1433published inCell Biochemistry and BiophysicsQ15755135
P1476titleAltered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells
P478volume55

Reverse relations

cites work (P2860)
Q28543175A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance
Q36289907Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways
Q61814607Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
Q36475888Predictive markers for the response to 5-fluorouracil therapy in cancer cells: Constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy
Q45849550Static magnetic field controls cell cycle in cultured human glioblastoma cells
Q33538053The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer
Q33866374Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine